Dermatofibrosarcoma Protuberans

• Published in: Current treatment options in oncology Vol. 18; no. 9; p. 56
• Main Authors: Acosta, Alvaro E., Vélez, Catalina Santa
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.09.2017; Springer Nature B.V
• Subjects: Biopsy; Clinical trials; Combined Modality Therapy - adverse effects; Combined Modality Therapy - methods; Dermatofibrosarcoma - diagnosis; Dermatofibrosarcoma - epidemiology; Dermatofibrosarcoma - etiology; Dermatofibrosarcoma - therapy; Dermatofibrosarcoma protuberans; Disease Management; Disease Susceptibility; Fascia; Genetic Predisposition to Disease; Head and neck; Humans; Imatinib; Inhibitor drugs; Medicine; Medicine & Public Health; Metastases; Metastasis; Multimodal Imaging - methods; Neoplasm Staging - methods; Oncology; Phenotype; Prognosis; Section Editor; Skin Cancer (SZ Aasi; Skin Neoplasms - diagnosis; Skin Neoplasms - epidemiology; Skin Neoplasms - etiology; Skin Neoplasms - therapy; Surgeons; Surgery; Targeted cancer therapy; Topical Collection on Skin Cancer; Treatment Outcome; Tumors; Mohs micrographic surgery; Pathology; Dermatofibrosarcoma protuberans; Radiotherapy; Surgery; Imatinib mesylate

Opinion statement Dermatofibrosarcoma protuberans (DFSP) is a slow growing tumor with a very low metastatic potential but with significant subclinical extension and great capacity for local destruction. Thus, the first surgeon approached with such challenging tumor must attempt to cure the patient w...